No, GLP-1 medications reduce biological hunger and enhance satiety but don't eliminate all cravings, particularly those driven by psychological factors, learned behaviors, or emotional eating patterns
The clinical consensus is clear: GLP-1 drugs are not magic
AARP Hearing Center Stephanie Al-Zubaidy learned the hard way about the side effects of GLP-1 medications
Over-the-counter products contain 1-2% glutathione and may include ingredients that boost glutathiones antioxidant activity, such as ascorbic acid, ferulic acid, and tocopherol
Role of GLP-1 Agonists and SGLT-2 on Diabetes and Kidney Disease Post Liver Transplant The emergence of Glucagon-like peptide-1 receptor (GLP-1) agonists and Sodium-glucose cotransporter-2 (SGLT-2) inhibitors as glucose-lowering therapies has opened new therapeutic avenues for managing patients with diabetic kidney disease
Thus, although an important point to keep attention to, data so far does not indicate that cardiovascular complications are a major cause for concern at the moment (gastrointestinal problems being by far the larger problem experienced by people on GLP1R agonists )